Results 61 to 70 of about 34,408 (196)

Human Immunodeficiency Virus (HIV)-Negative and Human Herpes Virus-8 (HHV-8)-Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature

Turkish Journal of Hematology, 2013
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that presents with serosal effusion in body cavities, without obvious tumor masses.
Sonay Güven Karataş, Reyhan Bayrak, Özlem Şahin Balçık, Kadir Serkan Yalçın, Esra Atıcı, Ümit Akyıldız, Ali Koşar   +6 more
doaj   +1 more source

PASD1: a promising target for the immunotherapy of haematological malignancies [PDF]

, 2013
In general, there is a lack of good immunotherapy targets within the spectrum of haematological malignancies. However haematopoietic stem cell transplants and continuing antigen discovery have allowed further insight into how further improvements in ...
Denniss, Frances, Guinn, Barbara-Ann, Khan, Ghazala, Mills, Ken I., Pulford, Karen   +4 more
core   +3 more sources

Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma [PDF]

Journal of Cutaneous Pathology, 2014
Primary effusion lymphoma (PEL) is a rare and aggressive lymphoma that arises in the context of immunosuppression and is characterized by co‐infection with Epstein–Barr virus (EBV) and human herpesvirus‐8/Kaposi sarcoma‐associated herpesvirus (HHV‐8/KSHV).
Genevieve M, Crane, Rena R, Xian, Kathleen H, Burns, Michael J, Borowitz, Amy S, Duffield, Janis M, Taube   +5 more
openaire   +2 more sources

Fluid Overload-Associated Large B-Cell Lymphoma Presenting as Isolated Pleural Effusion

Hematology Reports
Primary effusion-based lymphomas are uncommon and may pose significant diagnostic challenges. Fluid overload-associated large B-cell lymphoma is a recently recognized entity in the 5th edition of the World Health Organization Classification of ...
Kevin Leeper, Lauren Borecky, Mojtaba Akhtari, Jun Wang   +3 more
doaj   +1 more source

Extracavitary Manifestation of Primary Effusion Lymphoma as a Right Atrial Mass [PDF]

, 2013
Primary effusion lymphoma (PEL) is a subset of large B cell lymphomas and has been mostly associated with human immunodeficiency virus infection. Rare cases have been reported in organ transplant recipients and chronic hepatitis C patients.
Guddati, Achuta K, Marak, Creticus P., Ponea, Ana M., Shaheen, Shagufta, Shim, Chang   +4 more
core   +2 more sources

Current Concepts in Primary Effusion Lymphoma and Other Effusion-Based Lymphomas

Korean Journal of Pathology, 2014
Primary effusion lymphoma (PEL) is a human herpes virus 8 (HHV8)-positive large B-cell neoplasm that presents as an effusion with no detectable tumor in individuals with human immunodeficiency virus infection or other immune deficiencies. PEL is an aggressive neoplasm with a poor prognosis.
Kim, Yoonjung, Park, Chan Jeong, Roh, Jin, Huh, Jooryung   +3 more
openaire   +2 more sources

Multiple human herpesvirus-8 infection [PDF]

, 2003
In Malawian patients with Kaposi sarcoma (KS) and their relatives, we investigated nucleotide-sequence variation in human herpesvirus-8 (HHV-8) subgenomic DNA, amplified from oral and blood samples by use of polymerase chain reaction.
Beyari, MM, Cook, RD, Hodgson, TA, Kondowe, W, Molyneux, EM, Porter, SR, Scully, CM, Teo, CG   +7 more
core   +1 more source

Diagnostic yield of cytologic analysis of pericardial effusion in dogs. [PDF]

, 2014
BackgroundPericardial effusion cytology is believed by many to be of limited value, yet few studies have evaluated its diagnostic utility.ObjectivesTo determine the diagnostic utility of cytologic analysis of pericardial effusion in dogs and to determine
Burton, AG, Cagle, LA, Epstein, SE, Hopper, K, Mellema, MS, Owens, SD   +5 more
core   +2 more sources

Primary effusion lymphoma: current perspectives

OncoTargets and Therapy, 2018
Primary effusion lymphoma (PEL) is a rare and aggressive disease, affecting a unique population of patients who are often elderly or immunocompromised. PEL is associated with human herpesvirus type-8 infection and most commonly presents as malignant effusions of the body cavities.
Mayur Narkhede, Shagun Arora, Chaitra Ujjani   +2 more
openaire   +4 more sources

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Case Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino, Cristiano Cesaro, Enzo Zamparelli, Flavio Cesaro, Alba Palma, Raffaella Lucci, Pasquale Imitazione, Dino Casazza, Dario Amore   +8 more
doaj   +1 more source